Jean-Jacques Bienaim
2013
In 2013, Jean-Jacques Bienaim earned a total compensation of $11.4M as Chief Executive Officer at BioMarin Pharmaceutical, a 81% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,054,030 |
|---|---|
| Option Awards | $6,850,935 |
| Salary | $868,796 |
| Stock Awards | $2,563,218 |
| Other | $27,059 |
| Total | $11,364,038 |
Bienaim received $6.9M in option awards, accounting for 60% of the total pay in 2013.
Bienaim also received $1.1M in non-equity incentive plan, $868.8K in salary, $2.6M in stock awards and $27.1K in other compensation.
Rankings
In 2013, Jean-Jacques Bienaim's compensation ranked 309th out of 12,286 executives tracked by ExecPay. In other words, Bienaim earned more than 97.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 309 out of 12,286 | 98th |
Division Manufacturing | 95 out of 4,612 | 98th |
Major group Chemicals And Allied Products | 26 out of 1,462 | 98th |
Industry group Drugs | 18 out of 1,156 | 98th |
Industry Pharmaceutical Preparations | 16 out of 890 | 98th |
Source: SEC filing on April 25, 2016.
Bienaim's colleagues
We found five more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2013.
2013
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2013
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2013
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2013
G Davis
BioMarin Pharmaceutical
General Counsel
2013
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019